FdaApplication
BLA 761195
Identifiers
- fda_app_no: BLA761195
Properties
| Property | Value |
|---|---|
| applicant_name | Argenx BV |
| application_type | BLA |
| approval_date | 2021-12-17 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| VYVGART | EFGARTIGIMOD ALFA | 400MG/20ML (20MG/ML) | Injection |
1 product